Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHT.L Regulatory News (GHT)

  • There is currently no data for GHT

Trading Update

25 Jan 2016 07:00

RNS Number : 7935M
Gresham Computing PLC
25 January 2016
 

25 January 2016

 

Gresham Computing plc

 

CTC breakthrough drives profitable growth for Group

Gresham Computing plc (LSE: "GHT", "Gresham" or the "Group"), the leading software and services Group that specialises in providing real-time financial transaction control and enterprise data integrity software, provides the following trading update for the year ended 31 December 2015 ("FY 2015").

 

The Group expects to report revenues for the year up 16% to £14.8 million and Adjusted EBITDA* up 142% to £2.7 million in line with expectations.

 

Clareti Transaction Control (CTC) software sales were up 212% driving Group total software revenues ahead by 38%. Other non-CTC parts of the Group performed in line with expectations.

 

Recurring CTC software revenue continued the trend of consistent strong growth, increasing 90% on the previous period. During FY 2015 the Group signed a number of new clients in US, Europe and Asia Pacific and a number of existing customers increased their investment in the technology.

 

The Group closed the year with cash at £4.7 million, in line with expectations, and remains debt-free. The financial position is expected to remain strong throughout 2016 and beyond. The Group anticipate the results for FY 2015 will be announced in early March 2016.

 

Ian Manocha, CEO, commented:

"We are building a leadership position in a new category of enterprise data integrity leveraging our disruptive Clareti technology platform and an expanding applications portfolio for financial control, risk management and regulatory compliance.

 

Gresham made significant progress in 2015 with 11 new CTC customer wins. In addition, we launched our cloud platform Clareti-as-a-Service, strengthened the global organisation, and made further strategic investments into sales and marketing to sustain the positive momentum into 2016."

 

* Adjusted EBITDA refers to earnings before interest, tax, depreciation and amortisation, adjusted to add back share-based payment charges and exceptional items.

 

Enquiries:

Gresham Computing plc

Ian Manocha +44 (0) 207 653 0200

Rob Grubb

N+1 Singer (Broker)

Shaun Dobson +44 (0) 207 496 3000

Lauren Kettle

 

 

Note to editors

Gresham's award-winning software platform Clareti Transaction Control (CTC) has been designed to provide financial institutions with complete certainty in their data processing. CTC combines best-in-class performance with future-proofed technology, providing real-time data management based on business-driven controls. CTC is a highly flexible and fully scalable platform for assuring enterprise data integrity and is designed to address today's most challenging financial control, internal risk management and regulatory compliance problems.

Gresham Computing plc is a leading software and services company that specialises in providing real-time financial transaction control and enterprise data integrity solutions, and is listed on the main market of the London Stock Exchange (GHT.L). With over 30 years' experience and headquartered in the City of London, customers include some of the world's largest financial institutions, all of whom are served locally from offices located in Europe, North America and Asia Pacific.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUOBRNOAAUAR
Date   Source Headline
1st Aug 20165:25 pmRNSDirector Declaration
25th Jul 20167:00 amRNSTrading Update
1st Jul 201610:20 amRNSDirector/PDMR Shareholding
27th Jun 201611:23 amRNSDirector/PDMR Shareholding
20th Jun 20161:14 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSDirectors' Dealings and Issue of Equity
26th May 20162:01 pmRNSDirector/PDMR Shareholding
16th May 20168:45 amRNSDirector/PDMR Shareholding
28th Apr 201612:36 pmRNSResult of AGM
28th Apr 20167:00 amRNSAGM Statement
7th Apr 20167:00 amRNSPositive start to 2016 with four new CTC customers
31st Mar 20169:09 amRNSDirector/PDMR Shareholding
29th Mar 20168:22 amRNSDirector/PDMR Shareholding
23rd Mar 20162:40 pmRNSNotice of AGM
8th Mar 20167:00 amRNSFinal Results
25th Jan 20167:00 amRNSTrading Update
8th Jan 20169:04 amRNSDirector's Declaration
29th Dec 20157:00 amRNSDirector/PDMR Shareholding
21st Dec 201510:01 amRNSDirector/PDMR Shareholding
16th Dec 201512:51 pmRNSDirector/PDMR Shareholding
15th Dec 20157:00 amRNSRelease of CTC ARM V2.0
30th Nov 20153:54 pmRNSDirector/PDMR Shareholding
18th Nov 20157:00 amRNSHolding(s) in Company
17th Nov 201510:36 amRNSDirector/PDMR Shareholding
12th Nov 201511:13 amRNSIssue of Equity
9th Nov 20153:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:00 amRNSCTC Customer Wins
5th Oct 20153:05 pmRNSDirector/PDMR Shareholding
1st Sep 20153:36 pmRNSDirector/PDMR Shareholding
25th Aug 20154:22 pmRNSDirector/PDMR Shareholding
24th Aug 20155:09 pmRNSDirector/PDMR Shareholding
17th Aug 20151:47 pmRNSDirector/PDMR Shareholding
10th Aug 20157:00 amRNSHalf Yearly Report
15th Jul 20157:00 amRNSNotice of Interim Results
29th Jun 20157:00 amRNSCTC North America contract win
1st Jun 20153:05 pmRNSDirectors' Dealings
1st Jun 201512:29 pmRNSGrant of Options
1st Jun 20157:00 amRNSBoard Changes Effective
29th May 20151:30 pmRNSDirector/PDMR Shareholding
18th May 20152:36 pmRNSDirector/PDMR Shareholding
7th May 201512:18 pmRNSResult of AGM
7th May 20157:00 amRNSAGM Statement
27th Apr 201510:07 amRNSDirector/PDMR Shareholding
20th Apr 201511:15 amRNSDirector/PDMR Shareholding
9th Apr 201512:36 pmRNSDirector/PDMR Shareholding
7th Apr 20157:00 amRNSCTC Contract Win
31st Mar 201510:42 amRNSNotice of AGM
24th Mar 20157:01 amRNSProposed Resolution to Purchase Own Shares
24th Mar 20157:00 amRNSAnnual Financial Report
20th Mar 20153:27 pmRNSReduction of Capital Effective

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.